Hepatitis E caused by the Hepatitis E Virus (HEV) is a liver disease resulting in over 20 million cases every year. Hepatitis E is now considered by some scientists as an emerging issue as HEV is not only prevalent in developing countries but is increasingly detected in industrialized nations. In this paper, we try to provide evidence for this notion and what actions may need to be implemented to prevent further spreading of HEV. The prevalence of HEV, including its distinct genotype distribution in different geographic regions (including both developing countries and industrialized countries) will be discussed; further discussions of HEV treatments will include the availability and the mechanism of HEV vaccines and antiviral treatments used to treat and contain the disease. Additionally, the prevention and spreading of Hepatitis E disease will be discussed in the later section of the paper. With the presentation of HEV transmission route, infection regions, and treatment, we aim to raise the awareness of the general public toward this liver disease and discuss whether the high prevalence disease is an emerging disease worldwide. According to the data we collected, the rate of HEV infection is high and shows a trend of increasing, which leads to our conclusion and proves our hypothesis that Hepatitis E is a re-emerging disease.
KeywordsHepatitis E VirusVirologyTransmissionPreventionTreatment
Ding, N. (2017) Hepatitis E Is a Liver Disease Caused by Hepatitis E Virus (HEV) Transmitted through the Faecal-Oral Route. http://www.drhealthtopics.com/hepatitis-e-liver-disease-caused-hepatitis-e-virus-hev-transmitted-faecal-oral-route/
Kadir, S.M., Saleem-ur-Rehman, K., Benetou, K., Ahmad, D. and Abdullah, A. (2016) Ten Years of Disease Surveillance in Kashmir, India under Integrated Disease Surveillance Programme (IDSP) during 2006-2016. https://www.amhsr.org/articles/ten-years-of-disease-surveillance-in-kashmir-india-under-integrated-disease-surveillance-programme-idsp-during-20062016-4186.html
Leonad, N. (2016) Mikhail Balayan and the Bizarre Discovery of Hepatitis E Virus. https://norkinvirology.wordpress.com/2016/05/03/mikhail-balayan-and-the-bizarre-discovery-of-hepatitis-e-virus/
WHO, K. (2017) Hepatitis E. http://www.who.int/news-room/fact-sheets/detail/hepatitis-e
Daniel, C. and Olender, S. (2018) How Can You Prevent Diseases Spread by the Fecal-Oral Route? https://www.verywellhealth.com/what-is-the-fecal-oral-route-1760046
Kamar, N., Izopet, J., Pavio, N., Aggarwal, R., Labrique, A., Wedemeyer, H. and Dalton, H.R. (2017) Hepatitis E Virus Infection. https://www.ncbi.nlm.nih.gov/pubmed/29154369
de Alencar Arrais Guerra, J.A., Kampa, K.C., Morsoletto, D.G., Junior, A.P. and Ivantes, C.A. (2017) Hepatitis E: A Literature Review. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719195/
Pelosi, E. and Clarke, I. (2008) Hepatitis E: A Complex and Global Disease. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167588/
Ding, Q., Heller, B., Capuccino, J.M., Song, B., Nimgaonkar, I., Hrebikova, G., et al. (2017) Hepatitis E Virus ORF3 Is a Functional Ion Channel Required for Release of Infectious Particles. http://www.pnas.org/content/114/5/1147
Cao, D. and Meng, X. (2012) Molecular Biology and Replication of Hepatitis E Virus. https://www.nature.com/articles/emi20127
Song, Y. (2010) Studies of Hepatitis E Virus Genotypes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028963/
Pischke, S., Behrendt, P., Bock, C., Jilg, W., Manns, M. and Wedemeyer, H. (2014). Hepatitis E in Germany—An Under-Reported Infectious Disease. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174681/
Cornelia, A., Alexander, W., Helga, M., Marco, K., Heinz, E. and Georg, P. (2009) High HEV Presence in Four Different Wild Boar Populations in East and West Germany. https://www.sciencedirect.com/science/article/pii/S0378113509003174
Szabo, K. and ReimarJohneb, R. (2015) Detection of Hepatitis E Virus RNA in Raw Sausages and Liver Sausages from Retail in Germany Using an Optimized Method. https://www.sciencedirect.com/science/article/pii/S0168160515301264
Krumbholz, A., Joel, S., Dremsek, P., et al. (2014) Seroprevalence of Hepatitis E Virus (HEV) in Humans Living in High Pig Density Areas of Germany. Medical Microbiology and Immunology, 203, 273-282. https://link.springer.com/article/10.1007/s00430-014-0336-3
Bettinger, D.E.H.H., Kappert, O.M. and Wenzel, J. (2014) Transfusion-Transmitted Hepatitis E in Germany, 2013. Eurosurveillance, 19, pii: 20812. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES2014.19.21.20812
Vollmer, T., Diekmann, J., Johne, R., Eberhardt, M., Knabbe, C. and Dreier, J. (2012) Novel Approach for Detection of Hepatitis E Virus Infection in German Blood Donors. Journal of Clinical Microbiology, 50, 2708-2713.
Vollmer, T., Diekmann, J., Eberhardt, M., Knabbe, C. and Dreier, J. (2016) Hepatitis E in Blood Donors: Investigation of the Natural Course of Asymptomatic Infection, Germany, 2011. Eurosurveillance, 21. https://www.ncbi.nlm.nih.gov/pubmed/27608433
Jain, P., Prakash, S., Gupta, S., Singh, K.P., Shrivastava, S., Singh, D.D. and Jain, A. (2013) Prevalence of Hepatitis A Virus, Hepatitis B Virus, Hepatitis C Virus, Hepatitis D Virus and Hepatitis E Virus as Causes of Acute Viral Hepatitis in North India: A Hospital Based Study. Indian Journal of Medical Microbiology, 31, 261-265. https://www.ncbi.nlm.nih.gov/pubmed/23883712/
Tnn, N. (2013) Around 80% of Sewage in Indian Cities Flows into Water System. https://timesofindia.indiatimes.com/home/environment/pollution/Around-80-of-sewage-in-Indian-cities-flows-into-water-systems/articleshow/18804660.cms
Ippagunta, S., Sharma, B. and Aggarwal, R. (2007) Presence of Hepatitis E Virus in Sewage in Northern India: Frequency and Seasonal Pattern. Journal of Medical Virology, 79, 1827-1831. https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.21017
Helen, W. (2017) Seroprevalence and Risk Factors Associated with Hepatitis E Virus Infections among People and Pigs in Tibet, China. Acta Tropica, 172, 102-106. https://www.sciencedirect.com/science/article/pii/S0001706X17302875?via=ihub
Jia, Z., Yi, Y., Liu, J., Cao, J., Zhang, Y., Tian, R., Bi, S., et al. (2014) Epidemiology of Hepatitis E Virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006. PLoS ONE, 9, e110837. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215996/ https://doi.org/10.1371/journal.pone.0110837
Dong, C., Dai, X., Liang, J., Dong, M. and Meng, J. (2012) Seroprevalence of Hepatitis E Virus Varies Considerably among Chinese Provinces. Hepatitis Monthly, 12, 386-390. http://hepatmon.com/en/articles/70416.html
Worm, H.C. and Wirnsberger, G. (2004) Hepatitis E Vaccines: Progress and Prospects. Drugs, 64, 1517-1531. https://doi.org/10.2165/00003495-200464140-00002
Ahmad, I., Holla, R.P. and Jameel, S. (2011) Molecular Virology of Hepatitis E Virus. Virus Research, 161, 47-58. https://doi.org/10.1016/j.virusres.2011.02.011
Makar, G. (2007) Safety and Efficacy of a Recombinant Hepatitis E Vaccine. The New England Journal of Medicine, 356, 895-903. https://doi.org/10.1016/S0739-5930(08)70198-3
Zhang, J. (2015) Long-Term Efficacy of a Hepatitis E Vaccine. New England Journal of Medicine, 372, 1478-1478. https://doi.org/10.1056/NEJMoa1406011
Wut, T. (2015) Zhongguo Wuganyimian - Weiyufang Dailai Xiwang. http://news.medlive.cn/all/info-progress/show-45099_35.html
Us, C. (2018) Vaccines for Children Program (VFC). https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html
(2018) Germany GDP per Capita PPP 1990-2018. https://tradingeconomics.com/germany/gdp-per-capita-ppp
Vivek, R., Zachariah, U., Ramachandran, J., Eapen, C., Rajan, D. and Kang, G. (2013) Characterization of Hepatitis E Virus from Sporadic Hepatitis Cases and Sewage Samples from Vellore, South India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 107, 363-367. https://doi.org/10.1093/trstmh/trt030 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454524/
Domanovic, D., Tedder, R., Blümel, J., Zaaijer, H., Gallian, P., Niederhauser, C., Hewitt, P., et al. (2017) Hepatitis E and Blood Donation Safety in Selected European Countries: A Shift to Screening? Eurosurveillance, 22, 30514. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404480/ https://doi.org/10.2807/1560-7917.ES.2017.22.16.30514
Guo, Q., Yan, Q., Xiong, J., Ge, S., Shih, J., Ng, M., Xia, N., et al. (2009) Prevalence of Hepatitis E Virus in Chinese Blood Donors. Journal of Clinical Microbiology, 48, 317-318. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812292/ https://doi.org/10.1128/JCM.01466-09
Gajjar, M., Bhatnagar, N., Sonani, R., Gupta, S. and Patel, T. (2014) Hepatitis E Seroprevalence among Blood Donors: A Pilot Study from Western India. Asian Journal of Transfusion Science, 8, 29-31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943141/ https://doi.org/10.4103/0973-6247.126685
Wang, M., Yin, Y., He, M. and Liu, Y. (2016) Acute, Recent and Past HEV Infection among Voluntary Blood Donors in China: A Systematic Review and Meta-Analysis. PLoS ONE, 11, e0161089. http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0161089 https://doi.org/10.1371/journal.pone.0161089
Wen, G., Chen, C., Song, X., Tang, Z., Ji, W., Wang, S., Xia, N., et al. (2018) Long-Term HEV Carriers without Antibody Seroconversion among Eligible Immunocompetent Blood Donors. Emerging Microbes & Infections, 7, 125. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033859/ https://doi.org/10.1038/s41426-018-0125-y
BioPharm, W. (2013) HEV-IgM Testing Paper Box. http://www.ystwt.com/product/276519599
BioPharm, W. (2015) Hepatitis E Virus IGM Detection Reagent. http://www.wondfo.com.cn/product-165.html
(2017) Ribavirin—FDA Prescribing Information, Side Effects and Uses. https://www.drugs.com/pro/ribavirin.html
Goldszmid, R., Dzutsev, A. and Trinchieri, G. (2014) Host Immune Response to Infection and Cancer: Unexpected Commonalities. Cell Host & Microbe, 15, 295-305. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996827/ https://doi.org/10.1016/j.chom.2014.02.003
Kamar, N., et al. (2014) Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients. The New England Journal of Medicine, 370, 1111-1120. https://www.nejm.org/doi/full/10.1056/NEJMoa1215246 https://doi.org/10.1056/NEJMoa1215246
Yeh, M., Hsieh, M., Huang, C., Huang, C., Hsieh, M., Huang, J., Yu, M., et al. (2016) Long-Term Efficacy of Peg-Interferon/Ribavirin with and without Lamivudine Therapy for HBeAg-Positive Hepatitis B and C Dual Infection. Journal of Gastroenterology and Hepatology, 31, 835-841. https://www.ncbi.nlm.nih.gov/pubmed/26478984 https://doi.org/10.1111/jgh.13203
Kamar, N., Lhomme, S., Peron, O.M., Alric, L. and Izopet, J. (2016) Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses, 8, 222. http://www.mdpi.com/1999-4915/8/8/222/htm https://doi.org/10.3390/v8080222
(2018) Ribavirin Side Effects in Detail—Drugs.com. https://www.drugs.com/sfx/ribavirin-side-effects.html